Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHP677: I-MIBG Therapy for Refractory Neuroblastoma
NCT00013806Phase 2Unknown
- Sponsor
- National Center for Research Resources
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of Iobenguane I-131 in neuroblastoma, sponsored by National Center for Research Resources. Status: unknown.
02
Drugs
Iobenguane I-131
03
Conditions
neuroblastoma
Beyond the preview
Go deeper on NCT00013806.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00013806.